On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
On Jun. 4, 2020, the Bill & Melinda Gates Foundation announced a five-year, US$1.6 billion commitment to Gavi,…
On Jun. 4, 2020, the World Health Organization (WHO) welcomed funding commitments from Gavi, the Vaccine Alliance’s third…
On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…
On Jun. 4, 2020, Merck announced that the U.S. Food and Drug Administration (FDA) had approved a supplemental…
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
On Jun. 4, 2020, Agricultural Research Service scientists and their Oregon State University collaborators announced they had developed…
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
On Jun. 4, 2020, iBio announced initiation of preclinical immunization studies for its second COVID-19 vaccine platform. The…
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
On Jun. 4, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
On Jun. 4, 2020, the United Kingdom (UK) helped secure $7.4 billion in funding to support global vaccine…
On Jun. 3, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax have pledged…
On Jun. 3, 2020, in a nationwide study, National Institutes of Health (NIH) funded researchers found that the…
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
On Jun. 2, 2020, the National Institutes of Health (NIH) reported that early results showed that remdesivir benefited…
On Jun. 2, 2020, Agenus announced the U.S. Food and Drug Administration’s (FDA) clearance of AgenTus’ IND application…
On Jun. 2, 2020, Pfizer announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will…
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
On Jun. 1, 2020,The Government of the Democratic Republic of the Congo announced that a new outbreak of…
On Jun. 1, 2020, Gilead Sciences announced topline results from the Phase 3 SIMPLE trial in hospitalized patients…
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced that the Company, together with partner OntoChem GmbH, has…
On Jun. 1, 2020, the U.S. Department of Agriculture (USDA) and the U.S. Department of Agriculture (USDA) announced…
On Jun. 1, 2020, Eli Lilly announced patients have been dosed in the world’s first study of a…
On Jun. 1, 2020, Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as…
On Jun. 1, 2020, the Food and Drug Administration (FDA) announced it had issued an emergency use authorization…
On Jun. 1, 2020, Altimmune announced the U.S. Food and Drug Administration (FDA) had authorized the Company to…
On Jun. 1, 2020, LabCorp announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…